Products

AVIEW
Coreline Soft Co.
Cardiology AI
Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
AVIEW Lung Nodule CAD
Coreline Soft Co.
Cardiology AI
AVIEW Lung Nodule CAD is an AI-powered software by Coreline Soft Co. that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification.
AVIEW RT ACS
Coreline Soft Co.
Oncology AI
AI-based radiotherapy autocontouring system for efficient and accurate organ segmentation in radiation treatment planning.

See all 6 products →

About Coreline Soft

Coreline Soft is a South Korea-based healthcare AI company specializing in advanced 3D medical image analysis solutions, primarily for thoracic conditions. Their core technology leverages Explainable AI (XAI) to provide fully automated and accurate quantitative analysis of 3D medical images, offering critical supporting data to medical staff for enhanced diagnosis and treatment planning.

The company’s flagship AVIEW platform offers a comprehensive suite of products designed to improve patient care and outcomes. Key solutions include AVIEW LCS for lung cancer screening, AVIEW COPD for chronic obstructive pulmonary disease quantification, and AVIEW CAC for coronary artery calcification assessment. These tools assist in the early detection and structured analysis of major lung diseases, and they are expanding into advanced tools for interstitial lung disease (ILD), idiopathic pulmonary fibrosis (IPF), and infectious pneumonia. AVIEW solutions are clinically validated and nationally adopted, serving as an official AI provider for Korea’s nationwide lung cancer screening program and implemented in major European hospitals.

Focus Areas

AI-based 3D medical image analysis lung cancer screening COPD quantification coronary artery calcification interstitial lung disease (ILD) idiopathic pulmonary fibrosis (IPF) infectious pneumonia multimodal medical AI radiology cardiovascular medicine

Business Intelligence

Key InvestorsHanyang Securities, NH Investment & Securities Co. Ltd., Shinhan Securities Co. Ltd., Samsung Securities, Hi Investment
PartnershipsUniversity Hospital of Cologne (Germany), Blackford (Scotland), Lungscreen (global teleradiology), Oatmeal Health (US), Temple Health, Baylor College of Medicine, 3DR Labs (North America), Microsoft, Sol Radiology, Inc. (California, USA), Charité – Universitätsmedizin Berlin, INFINITT North America, National Cancer Institute of Milan (INT Milano) for RISP program (Italy), DMC Healthcare (UK), XCoorp GmbH (Europe), Erasmus MC, DKFZ Heidelberg, University Hospital of Essen
TechnologyAVIEW platform, XAI (Explainable AI) technology, cloud-based AI image data management, AI nodule detection engine (CADe), malignancy prediction algorithm (CADx), multimodal generalist models
FDA Clearances11 cleared products (estimated)

What Physicians Need to Know

AI-based 3D Medical Image Analysis
Coreline Soft specializes in advanced AI-driven 3D medical image analysis, forming the foundation of all its diagnostic solutions. Their AVIEW suite provides sophisticated algorithms for precise, automated assessments across various thoracic conditions.
Lung Cancer Screening (LCS)
AVIEW LCS and AVIEW LCS Plus offer AI-powered identification and assessment of pulmonary nodules from low-dose CT (LDCT) scans. The system classifies nodules (solid, part-solid, non-solid), measures size, volume, morphology, and location, and generates Lung-RADS scores. It also facilitates follow-up comparisons by automatically tracking nodule changes.
COPD Quantification
AVIEW COPD provides AI-based quantitative analysis of chest CT images for Chronic Obstructive Pulmonary Disease. It evaluates emphysema, low attenuation areas (LAA), vessel analysis, fissure integrity, air trapping, and airway measurements, offering objective metrics for diagnosis, follow-up, and documentation.
Coronary Artery Calcification (CAC)
AVIEW CAC is an AI software that quantifies coronary artery calcification and assesses the risk of coronary artery disease. It performs automatic segmentation of the heart and coronary arteries (LM, LAD, LCX, RCA), calculating Agatston, volume, and mass scores from both cardiac and non-gated chest CT scans.
Interstitial Lung Disease (ILD) & IPF Analysis
AVIEW Lung Texture provides fully automated quantitative analysis for Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF). It defines and quantifies fibrotic patterns (honeycomb, reticular, GGO, consolidation, emphysema) and classifies them by severity, aiding in early diagnosis and predicting survival in IPF patients. It also supports Interstitial Lung Abnormalities (ILA) analysis based on Fleischner Society guidelines.
Infectious Pneumonia
Coreline Soft's AVIEW Lung Texture solution includes features for pneumonia scoring, contributing to the comprehensive analysis of lung pathologies.
Multimodal Medical AI
Coreline Soft is actively involved in national projects to develop multimodal medical AI solutions. This includes combining thoracic CT-based multi-disease analysis with generative AI to create tailored solutions for various medical specialties like pediatrics, oncology, chronic diseases, and critical care, aiming to improve clinical workflows and research.
Radiology & Cardiovascular Medicine
Their solutions are designed to enhance efficiency and streamline workflow automation for radiologists and cardiovascular specialists. The AVIEW platform provides comprehensive reports and 3D reproductions, supporting diagnostic accuracy and clinical decision-making in thoracic and cardiovascular imaging.
Physician Tip

For physicians, Coreline Soft's AI solutions, particularly the AVIEW LCS Plus, offer a 'one scan for three diseases' approach, simultaneously detecting lung nodules, quantifying emphysema, and analyzing coronary artery calcification from a single low-dose CT. This significantly streamlines workflows, reduces reading times, and enhances diagnostic consistency and accuracy. The quantitative analysis provided for conditions like COPD and ILD offers objective metrics for disease severity, progression, and treatment response, reinforcing clinical judgment rather than replacing it. Their 'zero-click' integration with PACS systems ensures seamless adoption into existing clinical environments, minimizing workflow interruptions. Furthermore, the 3D reproductions facilitate intuitive patient explanations, improving patient understanding and engagement. The company's strong regulatory compliance and extensive real-world validation across national screening programs provide a high level of trust and reliability for clinical use.

Coreline Soft's AVIEW platform is designed for seamless integration into standard reading environments, including PACS (Picture Archiving and Communication Systems) and RIS (Radiological Information Systems). They offer deep-embed integrations, such as with INFINITT PACS, to enable a 'zero-click' AI workflow, allowing radiologists to access AI-powered insights directly within their familiar environment without extra steps. Solutions are available for cloud-based, hybrid, or on-premise deployment, supporting DICOM input/output formats and web-based viewers for accessibility. They also collaborate with AI marketplaces and distribution platforms.

Products by Coreline Soft

6 products in the directory

AVIEW
Coreline Soft Co.
Cardiology AI
Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
AVIEW Lung Nodule CAD
Coreline Soft Co.
Cardiology AI
AVIEW Lung Nodule CAD is an AI-powered software by Coreline Soft Co. that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification.
AVIEW RT ACS
Coreline Soft Co.
Oncology AI
AI-based radiotherapy autocontouring system for efficient and accurate organ segmentation in radiation treatment planning.
AVIEW LCS
Coreline Soft Co.
Cardiology AI
Coreline Soft's AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules. The AVIEW LCS Plus platform provides integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, enhancing diagnostic accuracy and streamlining radiology workflows.
A View LCS
Coreline Soft Co.
Cardiology AI
AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan.
AVIEW CAC
Coreline Soft Co.
Cardiology AI
AI-powered software for automated coronary artery calcium analysis from CT scans, providing quantitative results and risk assessment to aid in early detection and management of coronary artery disease.

What the Web Says

Coreline Soft is a software development company specializing in AI-driven medical imaging solutions, particularly for lung and heart conditions. Their flagship product, AVIEW, assists clinicians in analyzing CT scans for lung nodules, lung disease, and coronary artery calcium scoring. The company receives generally positive feedback for its technical expertise, communication, and project delivery. Employer reviews are limited but indicate a demanding environment with some concerns about career advancement, though management generally receives high approval.

Overall: Positive

Strengths

  • Strong UX/UI design capabilities
  • Effective project management and delivery
  • Proficiency in various technologies (AWS, DevOps, React Native, Vue)
  • Responsive and transparent communication
  • Products improve detection accuracy and reduce review time for radiologists
  • AI-powered solutions for lung nodule detection and cardiac risk assessment

Limitations

  • Challenges with developer transitions reported by one client
  • Limited reviews for employer experience
  • One employer review mentioned a stressful work environment with unrealistic expectations and no career advancement opportunities
  • Some reviews for a similarly named company (CoreLinc) mention low pay and few benefits

Based on reviews from: Clutch, Techreviewer, X-ray Interpreter, Indeed.com, AuntMinnie, KBR, Reddit, ParagonCare

Last updated: 2026-07-18

Videos

News, demos, and interviews about Coreline Soft.

Loading videos...

Videos load interactively. If none appear, search YouTube for Coreline Soft →

View all on YouTube

Press & Coverage

PR Newswire
Coreline Soft and Mint Medical Announce Partnership to Advance AI-Enabled Lung Cancer Screening
Coreline Soft and Mint Medical have partnered to advance AI-enabled lung cancer screening, integrating Coreline Soft's AVIEW imaging platform into Mint Medical's mint Lesion for structured reporting and standardized imaging data management. This collaboration is particularly relevant for Germany, where LDCT-based lung cancer screening is now reimbursed.
2026-06
Coreline Soft Updates page
Coreline Soft Launches U.S. Clinical Validation Program for Next-Generation AI Solutions
Coreline Soft has initiated a U.S. clinical validation program for its next-generation AI solutions. This move aims to further establish their AI technology in the American healthcare market.
2026-06
Seoul Economic Daily Finance News
Coreline Soft Gains from German Lung Cancer Screening as Subscription Shift Pays Off
Coreline Soft is seeing positive results from its shift to a subscription-based software-as-a-service (SaaS) business model, with SaaS revenue projected to exceed 50% this year. The company is expanding its AI solution AVIEW in Germany's lung cancer screening market, coinciding with new public healthcare AI contracts.
2026-06
PR Newswire
Coreline Soft Unveils 'G-BA Compliance-Optimized AI Infrastructure' in Step with Germany's Reimbursed Lung Cancer Screening Rollout
Coreline Soft has launched an AI infrastructure designed to comply with Germany's G-BA (Federal Joint Committee) requirements for reimbursed lung cancer screening. This aligns with Germany's new reimbursement framework for lung cancer screening, effective April 1, 2026.
2026-04
EQS News
Coreline Soft Aligns with Germany's New Lung Cancer Screening Reimbursement Framework from 2026, New Operational Requirements Introduced for Hospitals and Screening Programs
Germany's Federal Joint Committee (G-BA) has approved the inclusion of low-dose CT-based lung cancer screening into standard care, effective April 1, 2026, with Coreline Soft aligning its operational AI strategy to meet the new requirements for multi-center interpretation and quality management. The new framework emphasizes a process- and operations-driven screening model, requiring independent second readings and structured reporting.
2026-04
KBR
Coreline Soft sees usage-based revenue surge in US radiology deal
Coreline Soft renewed its contract with U.S. radiology services provider 3DR Labs for a fourth consecutive year, with monthly case volume increasing by 60% under a usage-based pricing structure. This renewal, which includes the migration of 3DR Labs to Coreline Soft's AVIEW 2.0 platform, is contributing to the company's recurring revenue growth in North America.
2026-06
FirstWord HealthTech
Coreline Soft Selected as Exclusive AI Provider for France's National Lung Cancer Screening Pilot Project, IMPULSION
Coreline Soft has been chosen as the exclusive AI supplier for IMPULSION, France's national lung cancer screening pilot study, funded by INCa and sponsored by AP-HP. The project, backed by u20ac6 million, will establish a nationwide AI supply system and provide training for physicians across more than 100 centers.
2025-11
Coreline Soft
Coreline Soft Joins 22B KRW National Multimodal Medical AI Project
Coreline Soft is participating in a government-funded AI research project worth 22 billion won (approximately $15.7 million USD) to develop multimodal models and a healthcare service support platform. This project, led by Seoul Asan Medical Center, aims to integrate various data types to improve medical quality and operational efficiency.
2025-08
No FAQs available yet for this company.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.